|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US6602900B2
(en)
|
1992-09-21 |
2003-08-05 |
Allergan, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
US5370313A
(en)
|
1994-01-10 |
1994-12-06 |
Beard; Walter C. |
Sterile liquid dispenser
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5578020A
(en)
|
1995-09-01 |
1996-11-26 |
Mosley; Manuel L. |
Drop dispensing apparatus
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(enExample)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6645963B2
(en)
|
1997-11-05 |
2003-11-11 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
CA2278328C
(en)
|
1998-02-09 |
2008-07-22 |
Macrochem Corporation |
Antifungal nail lacquer and method using same
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
CN1221249C
(zh)
|
1998-08-19 |
2005-10-05 |
斯凯伊药品加拿大公司 |
普鲁泊福的可注射水分散体
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
DE10042412B4
(de)
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
WO2002089849A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
TWI298257B
(en)
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
US20040265362A1
(en)
|
2001-09-04 |
2004-12-30 |
Rudy Susilo |
Plaster for the treatment of dysfunctions and disorders of nail growth
|
|
US7030149B2
(en)
*
|
2002-04-19 |
2006-04-18 |
Allergan, Inc. |
Combination of brimonidine timolol for topical ophthalmic use
|
|
WO2003099258A1
(de)
*
|
2002-05-24 |
2003-12-04 |
Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh |
Tropfbares ophthalmisches gelpräparat mit diclofenamid und timolol
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
EP1663148A2
(en)
|
2003-08-25 |
2006-06-07 |
Foamix Ltd. |
Penetrating pharmaceutical foam
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
CA2538856C
(en)
|
2003-10-10 |
2010-06-29 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
CA2540621A1
(en)
|
2003-11-19 |
2005-06-09 |
Barnes-Jewish Hospital |
Enhanced drug delivery
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
US20080019926A1
(en)
|
2004-04-19 |
2008-01-24 |
Marie-Pierre Krafft |
Lung Surfactant Supplements
|
|
EP1763336A1
(en)
|
2004-06-08 |
2007-03-21 |
Ocularis Pharma, Inc. |
Hydrophobic ophthalmic compositions and methods of use
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
AU2005262392A1
(en)
|
2004-07-01 |
2006-01-19 |
Johnson & Johnson Vision Care, Inc. |
Compositions and methods for treating eye disorders and conditions
|
|
CN101048136B
(zh)
*
|
2004-08-31 |
2011-06-22 |
施蒂福研究澳大利亚股份有限公司 |
微乳化和亚微米乳化方法和组合物
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
BRPI0614084A2
(pt)
|
2005-08-05 |
2011-03-09 |
Bharat Serums And Vaccines Limited |
composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005050431A1
(de)
|
2005-10-21 |
2007-04-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
US20070238732A1
(en)
|
2006-04-10 |
2007-10-11 |
Allergan, Inc. |
Brimonidine and timolol compositions
|
|
WO2008011836A2
(es)
|
2006-07-25 |
2008-01-31 |
Osmotica Corp. |
Soluciones oftálmicas
|
|
US20080089923A1
(en)
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
US9000048B2
(en)
|
2006-11-28 |
2015-04-07 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
KR20090087917A
(ko)
|
2006-12-07 |
2009-08-18 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
마이크로리터량의 액체를 방울의 형태로 분배하기 위한 계량된 방울 병
|
|
ITMI20070890A1
(it)
|
2007-05-04 |
2008-11-05 |
Sifi Spa |
Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
|
|
EP2178502A2
(en)
|
2007-06-21 |
2010-04-28 |
Yale University |
Sustained delivery of drugs from biodegradable polymeric microparticles
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
PL2110126T3
(pl)
|
2008-04-18 |
2012-04-30 |
Novaliq Gmbh |
Zastosowanie do inhalacji i zakraplania semifluorowanych alkanów jako nośników substancji aktywnych w strefie wewnątrzpłucnej
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
US8809261B2
(en)
|
2008-10-31 |
2014-08-19 |
Elsohly Laboratories, Incorporated |
Compositions containing delta-9-THC-amino acid esters and process of preparation
|
|
JP2012509737A
(ja)
|
2008-11-26 |
2012-04-26 |
サーモディクス，インコーポレイティド |
埋め込み式の眼薬送達器具および眼薬送達方法
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
JP5549669B2
(ja)
|
2009-06-25 |
2014-07-16 |
ライオン株式会社 |
眼科用組成物、ドライアイ治療剤及びビタミンａの安定化方法
|
|
PT2387391T
(pt)
|
2009-07-24 |
2017-04-20 |
Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh |
Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
WO2011112669A1
(en)
|
2010-03-09 |
2011-09-15 |
Centocor Ortho Biotech Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations
|
|
ES2564502T3
(es)
|
2010-03-17 |
2016-03-23 |
Novaliq Gmbh |
Composición farmacéutica para el tratamiento de la presión intraocular aumentada
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
*
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
*
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
EP2661280B1
(en)
|
2011-01-04 |
2018-11-21 |
Novaliq GmbH |
O/w-emulsions comprising semifluorinated alkanes
|
|
JP6039145B2
(ja)
|
2011-05-25 |
2016-12-07 |
ノバリック ゲーエムベーハー |
半フッ化アルカンを基礎にした局所薬学的組成物
|
|
CN103561724B
(zh)
|
2011-05-25 |
2016-06-29 |
诺瓦利克有限责任公司 |
给药给甲的药物组合物
|
|
JP2012250951A
(ja)
*
|
2011-06-06 |
2012-12-20 |
Santen Pharmaceut Co Ltd |
アデノシン誘導体とプロスタグランジン類とβ受容体遮断薬の組合せ剤
|
|
US8758826B2
(en)
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
PT2806886T
(pt)
|
2012-01-23 |
2017-03-24 |
Novaliq Gmbh |
Composições de proteínas estabilizadas baseadas em alcanos semifluorados
|
|
WO2013126602A1
(en)
|
2012-02-21 |
2013-08-29 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
EP2895144B1
(en)
|
2012-09-12 |
2017-01-11 |
Novaliq GmbH |
Semifluorinated alkane compositions
|
|
MX363182B
(es)
|
2012-09-12 |
2019-03-13 |
Novaliq Gmbh |
Composiciones que comprenden mezclas de alcanos semifluorados.
|
|
PL2708228T3
(pl)
|
2012-09-12 |
2018-11-30 |
Novaliq Gmbh |
Kompozycje do przemywania oczu
|
|
KR20150095684A
(ko)
|
2012-12-18 |
2015-08-21 |
노파르티스 아게 |
히알루로난에 결합하는 펩티드 태그를 이용하는 조성물 및 방법
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
DK3024484T3
(en)
|
2013-07-23 |
2018-10-08 |
Novaliq Gmbh |
STABILIZED ANTIBODY COMPOSITIONS
|
|
FR3013977A1
(fr)
|
2013-12-03 |
2015-06-05 |
Oreal |
Composition cosmetique comprenant des filtres uv
|
|
MX376125B
(es)
|
2014-03-31 |
2025-03-07 |
Amcor Rigid Plastics Usa Llc |
Recipiente de liberacion controlada.
|
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
WO2016025560A1
(en)
|
2014-08-13 |
2016-02-18 |
University Of Florida Research Foundation, Inc. |
Preservative removal from eye drops
|
|
US11285163B2
(en)
*
|
2014-10-20 |
2022-03-29 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|
|
WO2016082644A1
(en)
*
|
2014-11-26 |
2016-06-02 |
The University Of Hong Kong |
A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
|
|
EP3722274B1
(en)
|
2015-09-30 |
2023-06-07 |
Novaliq GmbH |
2-perfluorobutyl pentane for ophthalmic administration
|
|
US20170087100A1
(en)
|
2015-09-30 |
2017-03-30 |
Novaliq Gmbh |
Semifluorinated compounds and their compositions
|
|
JP2019517580A
(ja)
|
2016-06-01 |
2019-06-24 |
ハロルド・リチャード・ヘルストロムＨａｒｏｌｄ Ｒｉｃｈａｒｄ ＨＥＬＬＳＴＲＯＭ |
副交感神経薬および抗交感神経薬でのドライアイ疾患の処置
|
|
DK3442480T3
(da)
*
|
2016-06-23 |
2020-01-13 |
Novaliq Gmbh |
Fremgangsmåde til topisk indgivelse
|
|
WO2018033854A1
(en)
|
2016-08-15 |
2018-02-22 |
Santen Pharmaceutical Co., Ltd. |
Ophthalmic composition and a method for treating ocular hypertension and glaucoma
|
|
KR102614858B1
(ko)
|
2016-09-22 |
2023-12-18 |
노바리크 게엠베하 |
안검염 치료에 사용되는 약제학적 조성물
|
|
AU2017329983B2
(en)
|
2016-09-23 |
2022-05-05 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
CN109803650A
(zh)
|
2016-09-28 |
2019-05-24 |
诺瓦利克有限责任公司 |
包含大麻素受体结合配体的组合物
|
|
WO2018114557A1
(en)
|
2016-12-22 |
2018-06-28 |
Novaliq Gmbh |
Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
|
|
MX381639B
(es)
|
2016-12-23 |
2025-03-13 |
Novaliq Gmbh |
Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
|
|
PL3612228T3
(pl)
|
2017-04-21 |
2024-04-08 |
Dermaliq Therapeutics, Inc. |
Kompozycje jodu
|
|
US20210069014A1
(en)
|
2017-05-06 |
2021-03-11 |
Novaliq Gmbh |
Drop dispenser
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
JP7814839B2
(ja)
|
2017-09-27 |
2026-02-17 |
ノバリック ゲーエムベーハー |
眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
|
|
CN111182893A
(zh)
|
2017-10-04 |
2020-05-19 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
US11576893B2
(en)
|
2018-03-02 |
2023-02-14 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
|
AU2019246035B2
(en)
*
|
2018-03-28 |
2024-07-18 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
JP7855312B2
(ja)
|
2018-04-27 |
2026-05-08 |
ノバリック ゲーエムベーハー |
緑内障の治療のためのタフルプロストを含む眼科用組成物
|
|
EP3852734A1
(en)
|
2018-09-22 |
2021-07-28 |
Novaliq GmbH |
Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
|
|
CA3112031A1
(en)
|
2018-10-12 |
2020-04-16 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
CN113164609A
(zh)
|
2018-11-27 |
2021-07-23 |
诺瓦利克有限责任公司 |
包含ω-3脂肪酸乙酯的半氟化烷烃组合物
|
|
CN113518619A
(zh)
|
2019-01-21 |
2021-10-19 |
诺瓦利克有限责任公司 |
用于治疗眼部新生血管形成的药物组合物
|
|
EP3923907B1
(en)
|
2019-02-13 |
2024-09-25 |
Novaliq GmbH |
Compositions and methods for the treatment of ocular neovascularization
|
|
WO2020239646A1
(en)
|
2019-05-24 |
2020-12-03 |
Novaliq Gmbh |
Ophthalmic composition for the treatment of ocular allergy
|
|
JP2022543402A
(ja)
|
2019-08-09 |
2022-10-12 |
ノバリック ゲーエムベーハー |
プロスタグランジンアナログを含む局所組成物
|
|
CN114449999A
(zh)
|
2019-09-06 |
2022-05-06 |
诺瓦利克有限责任公司 |
用于治疗葡萄膜炎的眼用组合物
|